Sort by
Keyphrases
Lung Cancer
100%
EPHA5
100%
Tyrosine Kinase
100%
Radiation Resistance
100%
Radiation Therapy
37%
Radiosensitization
20%
Lung Cancer Cells
20%
SCell
10%
Receptor Tyrosine Kinase
10%
Biodistribution
10%
Human Lung Cancer
10%
DNA Damage
10%
Cell Cycle Checkpoint
10%
Non-small Cell Lung Cancer (NSCLC)
10%
Insults
10%
Molecular Mechanism
10%
In Vivo Screening
10%
Treatment Resistance
10%
Therapeutic Modalities
10%
DNA Repair
10%
Cell Surface Display
10%
Ionizing Radiation
10%
Treatment Outcome
10%
Cellular Response
10%
Ataxia Telangiectasia mutated
10%
Therapy Mechanism
10%
Cell Lung Cancer
10%
DNA Damage Response
10%
Screening Approach
10%
Tumor
10%
Phage
10%
Toxicology Studies
10%
Antibody Phage Display
10%
Tumor-bearing Mice
10%
Cancer Xenograft
10%
Therapeutic Goals
10%
Multiple Lines of Evidence
10%
Irradiation
10%
Hierarchical Approach
10%
Tumor Repopulation
6%
Therapy Success
6%
Radioresistance
6%
Targeted Inhibition
6%
Monoclonal Antibody
6%
Pharmacokinetics-pharmacodynamics (PK-PD)
6%
Biochemistry, Genetics and Molecular Biology
Receptor Tyrosine Kinase
100%
Tyrosine Kinase
100%
Cancer Cell
100%
Pharmacokinetics
50%
Cell Cycle Checkpoint
50%
DNA Damage Response
50%
S Cell
50%
DNA Damage
50%
Ataxia Telangiectasia Mutated
50%
Biodistribution
50%
DNA Repair
50%
Bacteriophage
50%
Pharmacodynamics
33%
Monoclonal Antibody
33%
Radiosensitivity
33%
Medicine and Dentistry
Lung Cancer
100%
Protein Tyrosine Kinase
100%
Radiation Therapy
61%
Cancer Cell
33%
Neoplasm
33%
Cell Cycle Checkpoint
16%
DNA Damage
16%
DNA Repair
16%
Biodistribution
16%
Therapeutic Modality
16%
Non Small Cell Lung Cancer
16%
Tumor Xenograft
16%
In Vitro
16%
Ataxia Telangiectasia
16%
DNA Damage Response
16%
Pharmacokinetics
16%
Ionizing Radiation
16%
Toxicology
16%
Bacteriophage
16%
Tumor Repopulation
11%
Monoclonal Antibody
11%
Radiosensitivity
11%
Pharmacodynamics
11%